Cytek Biosciences Inc.
CTKB | NASDAQ
$5.71
+$0.43 (+8.14%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -31.02M | -18.87M | -44.08M | -5.48M | -5.58M | -11.4M | 9.64M | 940K | -10.43M | -6.17M | 5.5M | -6.46M | -4.39M | -6.81M | 3.72M | 1.67M | -598K | -2.16M | -1.17M | 346K | 2.67M | 102K |
Depreciation & Amortization | 5.8M | 2.81M | 3.04M | 3.06M | 2.99M | 2.88M | 2.74M | 2.81M | 2.48M | 2.46M | 2.43M | 2.56M | 2.45M | 1.8M | 1.86M | 771K | 866K | 1.47M | 685K | 194K | 201K | 167K |
Stock-Based Compensation | 10.2M | 4.86M | 5.53M | 5.64M | 6.79M | 6.63M | 7M | 7.05M | 7.15M | 5.64M | 5.67M | 5.76M | 5.92M | 4.7M | 4.47M | 4.36M | n/a | 3.84M | 3.01M | n/a | 667K | 456K |
Other Working Capital | 3.93M | 590K | 1.93M | -1.34M | 1.37M | -2.33M | 1.57M | -9.49M | -1.72M | -7.78M | -8.64M | 1.76M | 681K | 521K | 2.25M | -6.99M | -523K | -1.02M | 5.7M | 2.51M | 1.01M | 1.82M |
Other Non-Cash Items | 650K | -359K | -366K | -928K | -1.25M | -930K | -11.89M | 12.37M | -1.1M | 179K | -246K | -831K | -1.74M | -528K | 886K | 1.69M | 5.28M | 572K | 913K | 4.03M | 346K | 653K |
Deferred Income Tax | -183K | -183K | 38.58M | -2.63M | -2.06M | -336K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 13.19M | 9M | -3.48M | -3.56M | -785K | 3.03M | -5.5M | -9.95M | 8.11M | 1.85M | -3.84M | -5.27M | -5.09M | 3.69M | -4.74M | -15.99M | -14.99M | -5.2M | 2.01M | -3.41M | -7.8M | 557K |
Operating Cash Flow | -1.37M | -2.74M | -771K | -3.9M | 108K | -125K | 2M | 13.22M | 6.2M | 3.96M | 9.51M | -4.24M | -2.85M | 2.86M | 6.19M | -7.5M | -9.44M | -1.48M | 5.45M | 1.16M | -3.91M | 1.94M |
Capital Expenditures | -4.38M | -2.17M | -1M | -655K | -1.58M | -851K | -903K | -808K | -1.2M | -622K | -1.56M | -1.39M | -1.37M | -505K | -6.61M | -1.11M | -1.33M | -780K | -1.3M | -1.31M | -1.25M | -509K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -471K | -76K | n/a | n/a | -1K | -1K | n/a | -44.9M | n/a | n/a | n/a | n/a | -17M | 371K | n/a | 371K |
Purchase of Investments | -156.9M | -95.6M | -77.11M | -59.62M | -81.26M | -60.16M | -107.25M | -52.83M | -36.85M | -77.13M | -23.37M | -23.48M | -5.84M | n/a | -44.45M | n/a | -1.59M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 141.28M | 70.71M | 76.11M | 79.2M | 66.48M | 70.43M | 45M | 38M | 40M | 72M | 54M | 68M | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -52K | -27K | 162K | 1K | -49K | 31K | 182K | -98K | -72K | -55K | -61K | -63K | -55K | -123.47M | -80K | -40K | n/a | n/a | n/a | -371K | n/a | n/a |
Investing Cash Flow | -20.06M | -27.08M | -1.84M | 18.92M | -16.41M | 9.45M | -63.43M | -15.81M | 2.02M | -5.75M | 29.07M | 43.12M | 2.79M | -168.87M | -51.06M | -1.15M | -2.92M | -780K | -18.3M | -1.31M | -1.25M | -138K |
Debt Repayment | 2.63M | 4.2M | -1.52M | 1.95M | 1.24M | -828K | 2.65M | -135K | -142K | 1.26M | -140K | -138K | -141K | -146K | -50K | n/a | n/a | n/a | n/a | n/a | -2.77M | n/a |
Common Stock Repurchased | n/a | n/a | 34K | 29K | -4.51M | -10.63M | -6.99M | -11.95M | -2.67M | n/a | -34.74M | -8.43M | -981K | -57K | n/a | -71K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 428K | -239K | -267K | -34K | -102K | -90K | 705K | 1K | 1.1M | -148K | 1.13M | 292K | -111K | 203K | 2.72M | 226K | 698K | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 3.17M | 3.98M | -1.23M | 1.94M | -2.6M | -11.55M | -3.64M | -12.08M | -1.71M | 1.61M | -33.75M | -8.27M | 216K | n/a | 3.85M | 155K | 1.14M | 364K | 17K | 217.08M | -3.72M | 187K |
Net Cash Flow | -17.01M | -25.19M | -2.43M | 17.81M | -19.83M | -3.45M | -63.56M | -15.62M | 8.78M | 1.51M | 4M | 32.09M | -850K | -167.11M | -42.02M | -8.37M | -12.61M | -2.11M | -12.15M | 216.93M | -8.74M | 2.47M |
Free Cash Flow | -5.75M | -4.9M | -1.77M | -4.55M | -1.47M | -976K | 1.09M | 12.41M | 5M | 3.34M | 7.95M | -5.63M | -4.22M | 2.35M | -417K | -8.61M | -10.77M | -2.26M | 4.15M | -147K | -5.17M | 1.43M |
Adj. Free Cash Flow | -15.95M | -9.77M | -7.3M | -10.19M | -8.26M | -7.61M | -5.91M | 5.36M | -2.15M | -2.31M | 2.28M | -11.39M | -10.14M | -2.35M | -4.88M | -12.97M | -10.77M | -6.1M | 1.14M | -147K | -5.83M | 970K |
Maintenance CapEx | -4.38M | -2.17M | -446.66K | -560.77K | -1.58M | -851K | -903K | -414.6K | -1.2M | n/a | -535.77K | -613.69K | -380.37K | -295.33K | -5.83M | -605.63K | -521.89K | n/a | -1.03M | -1.01M | -885.67K | -305.34K |
Growth CapEx | n/a | n/a | -554.34K | -94.23K | n/a | n/a | n/a | -393.4K | n/a | -622K | -1.03M | -779.31K | -987.63K | -209.67K | -780.57K | -504.37K | -806.12K | -780K | -268.19K | -300.77K | -365.33K | -203.66K |
Owner Earnings | -5.75M | -4.9M | -1.22M | -4.46M | -1.47M | -976K | 1.09M | 12.81M | 5M | 3.96M | 8.98M | -4.85M | -3.23M | 2.56M | 363.57K | -8.11M | -9.96M | -1.48M | 4.42M | 153.77K | -4.8M | 1.63M |
Add to Watchlist
Select watchlists to add or remove CTKB